Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine.
Saved in:
| Title: | Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine. |
|---|---|
| Authors: | Akahata W; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Komori M; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Morey AL; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Quiñones-Molina AA; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA., Hood JB; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA., Fofana J; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA., Romero L; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Peters E; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Webber JD; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Meeks T; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Przygonska PA; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Steinberg I; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Ober E; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Kim T; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Rogan DC; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Matsuda K; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Smith JF; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Gummuluru S; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA., Connors M; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Akiyama H; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2025 Nov 12; Vol. 17 (824), pp. eadz2276. Date of Electronic Publication: 2025 Nov 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41223248 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Akahata+W%22">Akahata W</searchLink>; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Komori+M%22">Komori M</searchLink>; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Morey+AL%22">Morey AL</searchLink>; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Quiñones-Molina+AA%22">Quiñones-Molina AA</searchLink>; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.<br /><searchLink fieldCode="AU" term="%22Hood+JB%22">Hood JB</searchLink>; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.<br /><searchLink fieldCode="AU" term="%22Fofana+J%22">Fofana J</searchLink>; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.<br /><searchLink fieldCode="AU" term="%22Romero+L%22">Romero L</searchLink>; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Peters+E%22">Peters E</searchLink>; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Webber+JD%22">Webber JD</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Meeks+T%22">Meeks T</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Przygonska+PA%22">Przygonska PA</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Steinberg+I%22">Steinberg I</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Ober+E%22">Ober E</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Kim+T%22">Kim T</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Rogan+DC%22">Rogan DC</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Matsuda+K%22">Matsuda K</searchLink>; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Smith+JF%22">Smith JF</searchLink>; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA.<br /><searchLink fieldCode="AU" term="%22Gummuluru+S%22">Gummuluru S</searchLink>; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.<br /><searchLink fieldCode="AU" term="%22Connors+M%22">Connors M</searchLink>; HIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Akiyama+H%22">Akiyama H</searchLink>; Department of Virology, Immunology & Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2025 Nov 12; Vol. 17 (824), pp. eadz2276. <i>Date of Electronic Publication: </i>2025 Nov 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41223248 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/scitranslmed.adz2276 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: eadz2276 Titles: – TitleFull: Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Akahata W – PersonEntity: Name: NameFull: Komori M – PersonEntity: Name: NameFull: Morey AL – PersonEntity: Name: NameFull: Quiñones-Molina AA – PersonEntity: Name: NameFull: Hood JB – PersonEntity: Name: NameFull: Fofana J – PersonEntity: Name: NameFull: Romero L – PersonEntity: Name: NameFull: Peters E – PersonEntity: Name: NameFull: Webber JD – PersonEntity: Name: NameFull: Meeks T – PersonEntity: Name: NameFull: Przygonska PA – PersonEntity: Name: NameFull: Steinberg I – PersonEntity: Name: NameFull: Ober E – PersonEntity: Name: NameFull: Kim T – PersonEntity: Name: NameFull: Rogan DC – PersonEntity: Name: NameFull: Matsuda K – PersonEntity: Name: NameFull: Smith JF – PersonEntity: Name: NameFull: Gummuluru S – PersonEntity: Name: NameFull: Connors M – PersonEntity: Name: NameFull: Akiyama H IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 11 Text: 2025 Nov 12 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1946-6242 Numbering: – Type: volume Value: 17 – Type: issue Value: 824 Titles: – TitleFull: Science translational medicine Type: main |
| ResultId | 1 |